RFI Ultrasound ST.docx

THIS REQUEST FOR INFORMATION (RFI) IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION.

SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e).

DISCLAIMER

This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.

RFI/SOURCES SOUGHT DESCRIPTION

This is NOT a solicitation announcement. This is an RFI Notice only. The purpose of this RFI Notice is to gain information about potential qualified sources and their size classification relative to NAICS 334510 (size standard of 1,250 Employees). Responses to this RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this RFI Notice, further RFIs and/or solicitation or other announcements may be published.

The Department of Veterans Affairs (VA) is seeking information on and sources capable of providing an Ultrasound for the VA San Diego Healthcare System.

Brand-Name Product Information:

Manufacturer: Fuji Film

Salient Characteristics:

FUJIFILM Sonosite ST Ultrasound System

1. Ultrasound

• The ultrasound system must be a compact, point-of-care ultrasound device designed for bedside examinations within emergency and critical care environments.

• The system must include a high-resolution clinical monitor integrated into the ST platform.

• The system must include a height-adjustable stand, head unit, and secure mounting configuration suitable for clinical workflow.

• The system must support rapid boot-up and minimal startup delay for emergent patient care.

• The system must be capable of image optimization presets for vascular, musculoskeletal, abdominal, cardiac, and procedural guidance applications.

2. Transducer The system must be compatible with and include the following transducers:

1. L19-5 high-frequency linear transducer o Must support superficial imaging, vascular access, and MSK applications.

2. L12-3 linear array transducer o Must support general linear imaging, soft tissue, lung, and procedural guidance.

3. P5-1 phased array transducer o Must support cardiac, thoracic, and abdominal emergency medicine applications.

Included transducers must carry a manufacturer's standard 5-year warranty unless otherwise specified.

3. Imaging & Software Requirements

• The system must provide high-resolution 2D B-mode imaging with Doppler capabilities appropriate for EMED clinical use.

The system must be compatible with Sonosite Institute online education platform offering >100 hours of point-of-care ultrasound training.

All software and manuals must be provided on USB or digital format (User Guide and Service Manual).

· The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required.

· If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include the company name, address, point of contact, and size of business pursuant to the following questions:

(1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of DRAFT/SALIENT CHARACTERISTICS/SOW requirements. For instances where your company cannot meet the DRAFT/SALIENT CHARACTERISTICS/SOW requirement(s), please explain. For instances where your company can meet the DRAFT/SALIENT CHARACTERISTICS/SOW requirement(s), please show how your company meets/exceeds each requirement.

(2) Please review the list of DRAFT/SALIENT CHARACTERISTICS/SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A.

(3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc.

(4) Is your company considered small under the NAICS code identified in this RFI?

(5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of DRAFT/SALIENT CHARACTERISTICS/SOW?

(6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available).

(7) If you’re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified.

(8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6?

(9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items?

(10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice?

(11) What is your lead time to deliver a single unit with all components? Is there scale in lead time with greater quantities? Please elaborate.

(12) What is estimated life span of your solution? What support/services does that entail?

(13) Does your proposed equipment have FDA clearance? Please specify what FDA clearance(s) have been obtained.

(14) Does your organization offer a leasing solution? Please elaborate.

(15) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract? If so, please provide the contract number(s).

(16) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract.

(17) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award.

(18) Please provide your SAM.gov Unique Entity ID/Cage Code number.

Buy America Compliance Respondents shall provide sufficient detail to determine compliance with the Buy American Act, including country of origin, domestic content, and availability of domestic alternatives. Responses should be complete and supported with verifiable information.

1. Please identify the country of origin for the end product(s) being offered. Include the location of final assembly/manufacture.

2. Please provide the percentage of domestic content (by cost) for each product(s). Describe the origin of the major components.

3. Does your product qualify as a “domestic end product” in accordance with the Buy American Act?

4. If the proposed product is not compliant, are you able to provide a BAA-compliant domestic alternative?

5. Please identify the manufacturer name and location for the product(s). Confirm whether the manufacturer is U.S.-based.

6. Identify the country of origin of each product and indicate whether the product qualifies as a U.S.-made or designated-country end product in accordance with the Trade Agreements Act Responses to this notice shall be submitted via email to Carlo.manuel@VA.gov. Telephone responses will not be accepted. Responses must be received no later than Friday, June 26, 2026, by 9:00 AM PST.

All responses to this RFI/Sources Sought will be used for planning purposes only. Responses to this RFI/Sources Sought Notice are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued because of the information provided from this RFI, all interested parties must respond to the specific posting separately in accordance with the specifications of that announcement.